Literature DB >> 6354922

Opsonization of various capsular (K) E. coli by the alternative complement pathway.

P Stevens, L S Young, S Adamu.   

Abstract

A virulence factor of E. coli K-1 is its capacity to avoid opsonization via the alternative complement pathway (ACP). Since it is not known if E. coli with other capsular (K) antigens have similar properties we examined various capsular E. coli for opsonization by the ACP. To assess opsonization we used whole blood luminol-dependent chemiluminescence (CL) and the magnesium salt of ethyleneglycol tetraacetic acid to block the classical pathway. E. coli K-types 6, 7, 27, 30, 42, 53, 57 and 75 were effectively opsonized via the ACP (greater than 65% of CL obtained with unchelated normal serum). K types 2 and 13 were opsonized by the ACP in both the high range greater than 65% and intermediate range 36-65%. Only K-types 1, 3, 5, 12 and 92 were poorly opsonized (less than 35%) by the ACP. The data demonstrate that most E. coli K-types were opsonized via the ACP. The poor opsonization of E. coli K3, 5, 12 and 92 by the ACP may be virulence factor for these bacteria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354922      PMCID: PMC1454253     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes.

Authors:  R C Allen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid.

Authors:  A Forsgren; P G Quie
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

4.  Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.

Authors:  B Kaijser; S Olling
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

5.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

6.  Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.

Authors:  H E Jasin
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

7.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

8.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

9.  Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92.

Authors:  M P Glode; J B Robbins; T Y Liu; E C Gotschlich; I Orskov; F Orskov
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

10.  Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.

Authors:  P Stevens; L S Young
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more
  8 in total

1.  Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 2.  Modulation of phagocytic cell function.

Authors:  P A Henricks; J Verhoef; F P Nijkamp
Journal:  Vet Res Commun       Date:  1986-05       Impact factor: 2.459

3.  Evidence for involvement of peptidoglycan in the triggering of an oxidative burst by Listeria monocytogenes in phagocytes.

Authors:  K A Remer; T Reimer; M Brcic; T W Jungi
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

4.  Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.

Authors:  Rubén Francés; José M González-Navajas; Pedro Zapater; Carlos Muñoz; Rocío Caño; Sonia Pascual; Dorkas Márquez; Francia Santana; Miguel Pérez-Mateo; José Such
Journal:  J Clin Immunol       Date:  2007-04-03       Impact factor: 8.317

5.  Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1.

Authors:  G Pluschke; M Achtman
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota.

Authors:  Janelle S Ayres; Norver J Trinidad; Russell E Vance
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

7.  LILRA2 selectively modulates LPS-mediated cytokine production and inhibits phagocytosis by monocytes.

Authors:  Hao K Lu; Ainslie Mitchell; Yasumi Endoh; Taline Hampartzoumian; Owen Huynh; Luis Borges; Carolyn Geczy; Katherine Bryant; Nicodemus Tedla
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  The Functional Amyloid Curli Protects Escherichia coli against Complement-Mediated Bactericidal Activity.

Authors:  Steven G Biesecker; Lauren K Nicastro; R Paul Wilson; Çağla Tükel
Journal:  Biomolecules       Date:  2018-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.